---
$id: https://graph.org.ai/products/commodity/51112006
$type: Product
source: UNSPSC
code: "51112006"
title: "Pazopanib"
class: "51112000"
classTitle: "Tyrosine kinase inhibitors"
family: "51110000"
familyTitle: "Antineoplastic agents"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Pazopanib

**UNSPSC Code**: 51112006
**Class**: [Tyrosine kinase inhibitors](Tyrosine kinase inhibitors.mdx)
**Family**: [Antineoplastic agents](../Antineoplastic agents.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a tyrosine kinase inhibitor, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7RN5DR86CK. European Medicines Agency schedules Pazopanib in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB29175. Pazopanib generally arises in the molecular formula C21H23N7O2S. The term PAZOPANIB is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 20, no. 3, 2006, list 56.) As of Q4 2014, PAZOPANIB remains the US FDA Preferred Term for this commodity. Pazopanib bears US NLM identifiers UMLS ID C1831796 and NCI Concept Code C74547. SMILES: CC1=C(C=C(C=C1)NC2=NC=CC(=N2)N(C)C3=CC4=NN(C(=C4C=C3)C)C)S(=O)(=O)N.

